The cytotoxicity and tumor growth inhibition of the formulations were evaluated in in vitro and in vivo studies, respectively [17], nevertheless, the sPLA2-assisted drug release profile could not be determined because of the absence of an appropriate bioassay. This evidence concerns the gene PLA2G2A and neoplasm.